Union Pacific (NYSE:UNP)’s stock had its “hold” rating restated by equities research analysts at Cowen in a research note issued on Tuesday. They currently have a $151.00 target price on the railroad operator’s stock. Cowen’s target price points to a potential downside of 7.25% from the stock’s previous close.
UNP has been the topic of several other reports. ValuEngine raised shares of Union Pacific from a “hold” rating to a “buy” rating in a report on Thursday, August 2nd. Deutsche Bank cut shares of Union Pacific from a “buy” rating to a “hold” rating and set a $162.00 price target on the stock. in a report on Tuesday, August 14th. Morgan Stanley increased their price target on shares of Union Pacific from $125.00 to $136.00 and gave the company an “equal weight” rating in a report on Friday, June 1st. Loop Capital increased their price target on shares of Union Pacific to $153.00 and gave the company a “hold” rating in a report on Friday, June 1st. Finally, Stifel Nicolaus set a $151.00 price target on shares of Union Pacific and gave the company a “hold” rating in a report on Thursday, May 24th. Two investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and thirteen have assigned a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $150.14.
Top 5 Safest Stocks To Invest In 2021: On Assignment Inc.(ASGN)
On Assignment, Inc., a diversified professional staffing firm, provides flexible and permanent staffing solutions in the United States, Europe, Canada, Australia, and New Zealand. The company?s Life Sciences segment provides contract and permanent life science professionals to clients in the biotechnology, pharmaceutical, food and beverage, personal care, chemical, medical device, automotive, municipal, education, and environmental industries. Its contract professionals include chemists, clinical research associates, clinical lab assistants, engineers, biologists, biochemists, microbiologists, molecular biologists, biostatisticians, drug safety specialists, SAS programmers, medical writers, food scientists, regulatory affairs specialists, lab assistants, and other skilled scientific professionals. The company?s Healthcare segment offers locally-based and traveling contract professionals that include nurses, specialty nurses, respiratory therapists, surgical technicians, imaging technicians, X-ray technicians, medical technologists, medical assistants, pharmacists, pharmacy technicians, respiratory therapists, phlebotomists, coders, billers, claims processors, and collections staff, as well as dental professionals. This segment serves hospitals, integrated delivery systems, imaging centers, clinics, physician offices, reference laboratories, universities, managed care organizations, and third-party administrators. Its Physician segment provides short and long-term locum tenens services, and full-service physician search and consulting services. The company?s IT and Engineering segment offers high-end contract and direct placement services of information technology and engineering professionals with expertise in specialized information technology; software and hardware engineering; and mechanical, electrical, validation, and telecommunications engineering fields. On Assignment, Inc. was founded in 1985 and is headquartered in Calabasas, Cali fornia.
- [By Stephan Byrd]
Jefferies Financial Group started coverage on shares of ASGN (NYSE:ASGN) in a research note issued to investors on Tuesday morning, Marketbeat Ratings reports. The brokerage issued a buy rating and a $70.00 target price on the business services provider’s stock.
- [By Motley Fool Transcribing]
On Assignment (NYSE:ASGN) Q4 2018 Earnings Conference CallFeb. 13, 2019 5:00 p.m. ET
Prepared Remarks Questions and Answers Call Participants
- [By Max Byerly]
Get a free copy of the Zacks research report on ASGN (ASGN)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Top 5 Safest Stocks To Invest In 2021: Civeo Corporation(CVEO)
Civeo Corporation provides remote site accommodations for the natural resource industry in Australia, Canada, and the United States. It also offers facility management services, including food services; customized facility management information systems that provide clients with the tools and information necessary to manage the allocation of contracted rooms and service days; and support services, such as housekeeping and janitorial services, facility maintenance, laundry, communications, supply chain and logistics management, power generation, and transportation and personnel logistics. In addition, the company provides rental fleet of modular facilities for short term accommodation needs; rental facilities for wellsite requirements comprising living quarters and equipment; and solutions for offshore accommodation needs which consists of rental fleet of approximately 500 accommodations for installation and use on offshore platforms, vessels, salvage/dredging barges, and ships. In addition, it develops and operates water and wastewater treatment plants in remote locations, which include sewage collection systems, sewage treatment plants, potable water treatment plants, and water distribution systems. Further, the company designs, engineers, produces, transports, and installs a range of modular or site-built facilities. It operates 17 lodges and villages with an aggregate of approximately 22,000 rooms. It serves independent oil and natural gas companies, mining companies, and oilfield and mining service companies. Civeo Corporation is based in Houston, Texas.
- [By Shane Hupp]
Civeo (NYSE:CVEO) was downgraded by research analysts at ValuEngine from a “buy” rating to a “hold” rating in a note issued to investors on Monday.
- [By Logan Wallace]
Civeo Corp (NYSE:CVEO)’s share price was up 5.8% during trading on Tuesday . The stock traded as high as $3.53 and last traded at $3.48. Approximately 766,001 shares changed hands during mid-day trading, an increase of 1% from the average daily volume of 754,849 shares. The stock had previously closed at $3.29.
- [By Steve Symington]
Still, several individual companies easily outran the broader market. Read on to learn why shares of ManTech International (NASDAQ:MANT), Civeo (NYSE:CVEO), and Deutsche Bank (NYSE:DB) each climbed higher today.
Top 5 Safest Stocks To Invest In 2021: LookSmart Ltd.(LOOK)
LookSmart, Ltd. operates as an online search advertising network solutions company that provides solutions for search advertisers and publishers. The company offers advertisers targeted, performance based search advertising via its Advertiser Network; and an Ad Center platform for customizable private-label advertiser solutions for online publishers. Its customers include intermediaries, who purchase clicks to sell into the affiliate networks of search engine providers; direct advertisers and their agencies; and self-service advertisers. The company was founded in 1996 and is headquartered in San Francisco, California.
- [By Stephan Byrd]
Lookers (LON:LOOK)’s stock had its “buy” rating restated by investment analysts at Peel Hunt in a note issued to investors on Friday.
- [By Shane Hupp]
Peel Hunt reissued their buy rating on shares of Lookers (LON:LOOK) in a research note issued to investors on Wednesday morning.
A number of other equities analysts also recently weighed in on the stock. Numis Securities reaffirmed a buy rating and issued a GBX 130 ($1.76) price target on shares of Lookers in a research note on Wednesday, March 7th. JPMorgan Chase upped their price target on shares of Lookers from GBX 109 ($1.48) to GBX 130 ($1.76) and gave the stock an overweight rating in a research note on Thursday, March 8th. Liberum Capital reaffirmed a buy rating and issued a GBX 145 ($1.97) price target on shares of Lookers in a research note on Wednesday, March 7th. Finally, Canaccord Genuity reaffirmed a buy rating and issued a GBX 146 ($1.98) price target on shares of Lookers in a research note on Monday, March 5th. One research analyst has rated the stock with a hold rating and six have given a buy rating to the stock. Lookers has an average rating of Buy and an average price target of GBX 137.71 ($1.87).
Top 5 Safest Stocks To Invest In 2021: Westport Innovations Inc(WPRT)
Westport Fuel Systems Inc (Westport), formerly Westport Innovations Inc, is a Canada-based provider of low-emission engine and fuel system technologies utilizing gaseous fuels. It operates through the Westport Operations segment. The Westport Operations segment designs, manufactures and sells compressed natural gas, liquefied natural gas, and liquefied petroleum gas components and systems to original equipment manufacturers and to aftermarket customers. Westport’s subsidiaries design and manufacture a range of components, including pressure regulators, injectors, electronic control units, valves and filters; sell monofuel, bi-fuel and dual-fuel diesel blend conversion kits, and also offer full engine management systems and solutions. The Westport Operations segment has a customer base in Europe and North America, as well as in Asia, South America, and Africa. Westport supports customers with natural gas and propane vehicle conversions through the Ford QVM program for Ford vehicles. Advisors’ Opinion:
- [By Peter Graham]
Small cap alternative fuel systems and component stock Westport Fuel Systems (NASDAQ: WPRT) just jumped almost 40% in morning trading after announcing that its Chinese joint venture had received certification from the Ministry of Ecology and Environment of China (MEE) for its 12-liter engine equipped with the HPDI 2.0TM fuel system (WP12HPDI) – meaning the Company is positioned to sell to truck original equipment manufacturers (OEMs) in China.
- [By Rich Smith]
Westport Fuel Systems (NASDAQ:WPRT) shareholders, who’ve watched their stock lose 45% of its value over the past year, got even more bad news today: Chief Financial Officer Michael Willis has resigned, and Westport doesn’t have a ready replacement.
- [By Max Byerly]
Westport Fuel Systems Inc (NASDAQ:WPRT) (TSE:WPRT) has earned a consensus recommendation of “Hold” from the eight analysts that are presently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and four have given a buy rating to the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $4.70.
- [By Max Byerly]
Westport Fuel Systems Inc (NASDAQ:WPRT) (TSE:WPRT)’s share price rose 10.3% during mid-day trading on Monday . The stock traded as high as $3.65 and last traded at $3.64. Approximately 1,445,750 shares were traded during mid-day trading, an increase of 67% from the average daily volume of 867,994 shares. The stock had previously closed at $3.30.
Top 5 Safest Stocks To Invest In 2021: Endocyte, Inc.(ECYT)
We are a biopharmaceutical company developing targeted therapies for the treatment of cancer and inflammatory diseases. We use our proprietary technology to create novel small molecule drug conjugates, or SMDCs, and companion imaging agents. Our SMDCs actively target receptors that are over-expressed on diseased cells, relative to healthy cells. This targeted approach is designed to enable the treatment of patients with highly active drugs at greater doses, delivered more frequently, and over longer periods of time than would be possible with the untargeted drug alone. We are also developing companion imaging agents for each of our SMDCs that are designed to identify the patients whose disease over-expresses the target of the therapy and who are therefore likely to benefit from treatment. Advisors’ Opinion:
- [By Logan Wallace]
Endocyte, Inc. (NASDAQ:ECYT) gapped up prior to trading on Tuesday . The stock had previously closed at $16.70, but opened at $18.00. Endocyte shares last traded at $19.49, with a volume of 145358 shares changing hands.
- [By Chris Lange]
Endocyte Inc. (NASDAQ: ECYT) filed with the U.S. Securities and Exchange Commission (SEC) for a secondary offering. In most cases where a company does this, we see the stock drop. However, in this case investors are cheering Endocyte and its secondary offering.
- [By Cory Renauer]
If these high-flying drugmakers are going to continue their climb, they have to cross some well-defined hurdles in front of them. Here’s a look at what’s ahead.
Company (Symbol) 1-Year Gain Recent Market Cap
Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) 535% $1.8 billion
Viking Therapeutics, Inc. (NASDAQ:VKTX) 880% $725 million
Endocyte, Inc. (NASDAQ:ECYT) 1,140% $1.2 billion
Data source: Yahoo! Finance.
- [By Brian Orelli]
Shares of Endocyte (NASDAQ:ECYT) closed up 11.4% on Monday after the company disclosed that the U.S. Food and Drug Administration will allow it to use radiographic progression-free survival (rPFS) as an endpoint in its clinical trial — the Vision study — being conducted to support the approval of 177Lu-PSMA-617 for the treatment of metastatic castration-resistant prostate cancer.